Attention and Eye Movement in Parkinson's Disease
Eligible age
19–90 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this observational and interventional study is to understand how therapeutic deep brain stimulation (DBS) affects attention, perception and cognition in participants with Parkinson's disease (PD) and non-PD movement disorders, including essential tremor (ET) and dystonia (DT). The main questions it aims to answer are: * Does impaired control of attention and eye movement in PD alter how social cues are perceived and interpreted? * Does therapeutic DBS improve or worsen attentional and perceptual deficits for social cues in PD, ET and DT? * Can DBS be optimized to restore normal attentional control in PD while remaining an effective therapy for other aspects of the disorder. * What do parts of the brain targeted by DBS contribute to the control of attention? Using an eye tracking camera, investigators will study how participants with PD, ET and DT look at and perceive facial expressions of emotion before and after starting DBS therapy, in comparison to a group of healthy participants without ET, PD, DT or DBS. Participants with PD, ET and DT will see and rate morphed facial expressions on a computer screen in three conditions: * Before starting DBS therapy (over approximately 1 hour). * In the operating room, during the standard procedure to implant DBS electrodes, while the participant is awake (for no more than 15 minutes). * After starting DBS therapy, with brief experimental changes of DBS stimulation level and frequency (over approximately 1 hour).
Sponsor: University of Nebraska
You may qualify if…
- ✓ All Participants (Aim 1):
- ✓ Ability and willingness to provide signed informed consent for this study
- ✓ Ability to express perceptual judgments through a button press or mouse- controlled computerized slider
- ✓ Age 19 - 90 years
- ✓ DBS Participants (Aim 1):
- ✓ Diagnosis of idiopathic Parkinson's disease (PD), essential tremor (ET) or dystonia (DT).
- ✓ Scheduled for new implantation of a therapeutic DBS device targeted to subthalamic nucleus (STN), ventral intermediate nucleus of thalamus (VIM) or internal globus pallidus (GPi)
- ✓ Comparison Participants (Aim 1):
You may not qualify if…
- ✕ All Participants (Aim 1):
- ✕ Corrected visual acuity insufficient to perceptually judge face stimuli
- ✕ Inability to understand task instructions or complete task requirements
- ✕ DBS Participants (Aim 1):
- ✕ o Insufficient therapeutic control of motor symptoms to engage in tasks requiring button press or use of a mouse to control a slider
- ✕ Healthy Comparison Participants (Aim 1):
- ✕ o History of neurodegenerative disorder
- ✕ Parkinson's disease (PD), essential tremor (ET) and dystonia (DT) Participants (Aim 2):
Where it's recruiting
Omaha
Source: ClinicalTrials.gov · NCT06899022 · last updated 2026-05-05